induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicology and Applied Pharmacology, 223 (1), 46–55. doi:10.1016/j.taap.2007.05.006
Recursos adicionais Baggott, C., Fochtman, D., Foley, G. V. e Kelly, K. P. (Eds.). (2011). Nursing care of children and adolescents with cancer and blood disorders (4th ed.). Glenview, IL: Association of Pediatric Hematology/Oncology Nurses. Eisenberg, S. (2016). A call to action for hazardous drug safety: Where we have been and where we are now. Clinical Journal of Oncology Nursing, 20 (4), 377–384. doi:10.1188/16.CJON.20-04AP Goodin, S. (2007a). Advancing the safe and appropriate use of oral chemotherapy agents. American Journal of Health-System Pharmacy, 64 (9 Suppl. 5), S3. doi:10.2146/ajhp070033 Hon, C. Y., Teschke, K., Chua, P., Venners, S. e Nakashima, L. (2011). Occupational exposure to antineoplastic drugs: Identification of job categories potentially exposed throughout the hospital medication system. Safety and Health at Work, 2, 273-–281. doi:10.5491/ SHAW.2011.2.3.273 Massoomi, F. (2014). USP <800> and the expected impact on health systems . Extraído de: http://www.pharmacyadvisor.com/resources/ uploads/webinar_handouts/55/usp_800_and_the_expected_impact_ on_health_systems.pdf Ursani, C. L., Cavallo, D., Colombi, A., Giglio, M., Marinaccio, A. e Iavicoli, S. (2006). Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs. International Archives of Occupational and Environmental Health, 80 (2), 134–140. doi:10.1007/s00420-006-0111-x
Thompson, C. A. (2016, February). Standards on handling hazardous drugs issued by USP . ASHP. Extraído de: https://www.ashp.org/news/2016/02/01/ standards_on_handling_hazardous_drugs_issued_by_usp U.S. Pharmacopeial Convention. (2016). General chapter <800> Hazardous drugs—Handling in healthcare
settings . Extraído de: http://www.usp.org/usp-nf/notices/ general-chapter-hazardous-drugs-handling-healthcare-settings Valanis, B., Vollmer, W. M. e Steele, P. (1999). Occupational exposure to antineoplastic agents: Self-reported miscarriages and stillbirths among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 41 (8), 632–638. doi:10.1097/00043764-199908000-00004 Walsh, K. E., Roblin, D. W., Weingart, S. N., Houlahan, K. E., Degar, B., Billett, A., . . . Mazor, K. M. (2013). Medication errors in the home: A multisite study in children with cancer. Pediatrics, 131 (5), e1405– 1404. doi:10.1542/peds.2012-2434 Weingart, S. N., Brown, E., Bach, P. B., Eng, K., Johnson, S. A., Kuzel, T., . . . Walters, R. S. (2008). NCCN task force report: Oral chemotherapy. Journal of the National Comprehensive Cancer Network, 6 (Suppl. 3), S1–S14. Wick, C., Slawson, M. H., Jorgenson, J. A. e Tyler, L. S. (2003). Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. American Journal of Health-System Pharmacy, 60 (22), 2314–2320. Yoshida, J., Koda, S., Nishida, S., Yoshida, T., Miyajima, K. e Kumagai, S. (2011). Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan. Journal of Oncology Pharmacy Practice, 17 (1), 29-38. doi:10.1177/1078155210380485
162 Plano de Estudos de Quimioterapia e Bioterapia Pediátrica: Quarta Edição
Powered by FlippingBook